These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 38500369)

  • 1. A quantitative review of nanotechnology-based therapeutics for kidney diseases.
    Cheng HT; Ngoc Ta YN; Hsia T; Chen Y
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2024; 16(2):e1953. PubMed ID: 38500369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delivery of sorafenib by myofibroblast-targeted nanoparticles for the treatment of renal fibrosis.
    Cheng HT; Huang HC; Lee TY; Liao YH; Sheng YH; Jin PR; Huang KW; Chen LH; Chen YT; Liu ZY; Lin TC; Wang HC; Chao CH; Juang IP; Su CT; Huang KH; Lin SL; Wang J; Sung YC; Chen Y
    J Control Release; 2022 Jun; 346():169-179. PubMed ID: 35429575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multifunctional Nanocarriers for diagnostics, drug delivery and targeted treatment across blood-brain barrier: perspectives on tracking and neuroimaging.
    Bhaskar S; Tian F; Stoeger T; Kreyling W; de la Fuente JM; Grazú V; Borm P; Estrada G; Ntziachristos V; Razansky D
    Part Fibre Toxicol; 2010 Mar; 7():3. PubMed ID: 20199661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanocarrier-based localized and effective treatment of renal disorders: currently employed targeting strategies.
    Ullah S; Burki S; Munir AB; Yousaf G; Shafique M
    Nanomedicine (Lond); 2024 Feb; 19(4):345-361. PubMed ID: 38293889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of nanotechnology in drug delivery systems for respiratory diseases (Review).
    Luo MX; Hua S; Shang QY
    Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33760125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The development of site-specific drug delivery nanocarriers based on receptor mediation.
    Wang X; Li S; Shi Y; Chuan X; Li J; Zhong T; Zhang H; Dai W; He B; Zhang Q
    J Control Release; 2014 Nov; 193():139-53. PubMed ID: 24862317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanosize drug delivery system.
    Mukherjee B
    Curr Pharm Biotechnol; 2013; 14(15):1221. PubMed ID: 25106648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanocarriers based novel and effective drug delivery system.
    Khizar S; Alrushaid N; Alam Khan F; Zine N; Jaffrezic-Renault N; Errachid A; Elaissari A
    Int J Pharm; 2023 Feb; 632():122570. PubMed ID: 36587775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanocarriers in photodynamic therapy-in vitro and in vivo studies.
    Sztandera K; Gorzkiewicz M; Klajnert-Maculewicz B
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2020 May; 12(3):e1509. PubMed ID: 31692285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanoparticle Delivery Systems for DNA/RNA and their Potential Applications in Nanomedicine.
    Shen H; Huang X; Min J; Le S; Wang Q; Wang X; Dogan AA; Liu X; Zhang P; Draz MS; Xiao J
    Curr Top Med Chem; 2019; 19(27):2507-2523. PubMed ID: 31775591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting of nanoparticles in cancer: drug delivery and diagnostics.
    Talekar M; Kendall J; Denny W; Garg S
    Anticancer Drugs; 2011 Nov; 22(10):949-62. PubMed ID: 21970851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The development of nanocarriers for natural products.
    Huang L; Luo S; Tong S; Lv Z; Wu J
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2024; 16(3):e1967. PubMed ID: 38757428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-targeting delivery of herb-based drugs with cell-penetrating/tumor-targeting peptide-modified nanocarriers.
    Kebebe D; Liu Y; Wu Y; Vilakhamxay M; Liu Z; Li J
    Int J Nanomedicine; 2018; 13():1425-1442. PubMed ID: 29563797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Applications of Nanotechnology-mediated Herbal Nanosystems for Ophthalmic Drug.
    Shree D; Patra CN; Sahoo BM
    Pharm Nanotechnol; 2024; 12(3):229-250. PubMed ID: 37587812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detecting and destroying cancer cells in more than one way with noble metals and different confinement properties on the nanoscale.
    Dreaden EC; El-Sayed MA
    Acc Chem Res; 2012 Nov; 45(11):1854-65. PubMed ID: 22546051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanotechnology in therapeutics: a focus on nanoparticles as a drug delivery system.
    Bamrungsap S; Zhao Z; Chen T; Wang L; Li C; Fu T; Tan W
    Nanomedicine (Lond); 2012 Aug; 7(8):1253-71. PubMed ID: 22931450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances in galactose-engineered nanocarriers for the site-specific delivery of siRNA and anticancer drugs.
    Jain A; Jain A; Parajuli P; Mishra V; Ghoshal G; Singh B; Shivhare US; Katare OP; Kesharwani P
    Drug Discov Today; 2018 May; 23(5):960-973. PubMed ID: 29129804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanotechnology in cancer therapy.
    Aslan B; Ozpolat B; Sood AK; Lopez-Berestein G
    J Drug Target; 2013 Dec; 21(10):904-13. PubMed ID: 24079419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improving kidney targeting: The influence of nanoparticle physicochemical properties on kidney interactions.
    Huang Y; Wang J; Jiang K; Chung EJ
    J Control Release; 2021 Jun; 334():127-137. PubMed ID: 33892054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.